2021Oxford University Press eBooksRequires access

Yellow brains and blue light

Michael Obladen

Open publisher page 0 citations

Abstract

Fetal dropsy and neonatal jaundice were well known in the 17th century, but considered to be different diseases. Basal brain ganglia stained yellow were observed by Antoine Dugès in 1821, who also suggested that this finding may be associated with seizures. From observing kernicterus to understanding haemolytic disease of the newborn, 140 years passed, and the entire field of immunology had to develop. Only 25 years passed from understanding isoimmunization to the availability of effective prevention. With exchange transfusions, an effective but risky treatment for haemolytic disease and severe jaundice evolved in the 1940s. With some hesitation in the US, phototherapy followed in the 1950s. Rhesus haemolytic disease was practically eradicated during the 1960s by anti-D immunoglobulin. Kernicterus returned in the 1990s because of lessened awareness, and difficulty in monitoring bilirubin values after early discharge from maternity wards.

About this research paper

What this paper is about

Fetal dropsy and neonatal jaundice were well known in the 17th century, but considered to be different diseases. Basal brain ganglia stained yellow were observed by Antoine Dugès in 1821, who also suggested that this finding may be associated with seizures. From observing kernicterus to understanding haemolytic disease of the newborn, 140 years passed, and the entire field of immunology had to develop. Only 25 years passed from understanding isoimmunization to the availability of effective prevention. With exchange transfusions, an effective but risky treatment for haemolytic disease and severe jaundice evolved in the 1940s. With some hesitation in the US, phototherapy followed in the 1950s. Rhesus haemolytic disease was practically eradicated during the 1960s by anti-D immunoglobulin. Kernicterus returned in the 1990s because of lessened awareness, and difficulty in monitoring bilirubin values after early discharge from maternity wards.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Fetal dropsy and neonatal jaundice were well known in the 17th century, but considered to be different diseases. Basal brain ganglia stained yellow were observed by Antoine Dugès in 1821, who also suggested that this finding may be associated with seizures. From observing kernicterus to understanding haemolytic disease of the newborn, 140 years passed, and the entire field of immunology had to develop. Only 25 years passed from understanding isoimmunization to the availability of effective prevention. With exchange transfusions, an effective but risky treatment for haemolytic disease and severe jaundice evolved in the 1940s. With some hesitation in the US, phototherapy followed in the 1950s. Rhesus haemolytic disease was practically eradicated during the 1960s by anti-D immunoglobulin. Kernicterus returned in the 1990s because of lessened awareness, and difficulty in monitoring bilirubin values after early discharge from maternity wards.

Key concepts: Kernicterus, Haemolytic disease, Jaundice, Exchange transfusion, Medicine, Disease, Pediatrics, Hemolytic disease of the newborn (ABO)

Related papers

Back to paper searchBrowse research topicsOriginal source
Yellow brains and blue light — Research Paper | ScholarLens